Back to top
more

Alphatec (ATEC)

(Delayed Data from NSDQ)

$12.34 USD

12.34
2,314,874

-0.17 (-1.36%)

Updated Apr 18, 2024 04:00 PM ET

After-Market: $12.34 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -32.14% and 0.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -43.33% and 6.12%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Alphatec (ATEC) Surges 8.8%: Is This an Indication of Further Gains?

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -25% and 0.93%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Masimo (MASI) Q1 Earnings Expected to Decline

Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Alphatec (ATEC) Report Negative Earnings Next Week? What You Should Know

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -10% and 0.23%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Alphatec (ATEC) Soars 8.4%: Is Further Upside Left in the Stock?

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -9.38% and 3.18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Globus Medical (GMED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Alphatec (ATEC) Report Negative Earnings Next Week? What You Should Know

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wall Street Analysts Believe Alphatec (ATEC) Could Rally 77%: Here's is How to Trade

The mean of analysts' price targets for Alphatec (ATEC) points to a 76.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Alphatec (ATEC) Soars 7%: Is Further Upside Left in the Stock?

Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -2.86% and 7.80%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Si-Bone (SIBN) to Report a Decline in Earnings: What to Look Out for

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Alphatec (ATEC) to Report a Decline in Earnings: What to Look Out for

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -48.28% and 4.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Repro Med Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates

Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 16.67% and 4.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Alphatec (ATEC): Can Its 12.1% Jump Turn into More Strength?

Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

LENSAR, Inc. (LNSR) Moves 13.5% Higher: Will This Strength Last?

LENSAR, Inc. (LNSR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -29.03% and 0.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Orthofix (OFIX) Tops Q4 Earnings and Revenue Estimates

Orthofix (OFIX) delivered earnings and revenue surprises of 107.69% and 0.13%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ViewRay (VRAY) Reports Q4 Loss, Tops Revenue Estimates

ViewRay (VRAY) delivered earnings and revenue surprises of -6.67% and 2.76%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Nevro (NVRO) delivered earnings and revenue surprises of 0% and 0.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Idexx Laboratories (IDXX) Tops Q4 Earnings and Revenue Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 13.17% and 2.67%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?